The obesity paradox in acute coronary syndrome: a meta-analysis

European Journal of Epidemiology

Volumn 29, Issue 11, 2014, Pages 801-812

  Niedziela, Jacek ^a   Hudzik, Bartosz ^a   Niedziela, Natalia ^a   Gąsior, Mariusz ^a   Gierlotka, Marek ^a   Wasilewski, Jarosław ^a   Myrda, Krzysztof ^a   Lekston, Andrzej ^a   Poloński, Lech ^a   Rozentryt, Piotr ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute coronary syndrome; Body mass index; Obesity; Obesity paradox

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FUNCTION; META ANALYSIS; OBESITY; REVIEW; SEX RATIO; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; WEIGHT REDUCTION; COMPLICATION; FEMALE; KAPLAN MEIER METHOD; MALE; MORTALITY;

ACUTE CORONARY SYNDROME; BODY MASS INDEX; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; OBESITY;

EID: 84922392089     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-014-9961-9     Document Type: Review

References (54)

1. OED Online [database on the Internet]. Oxford University Press. 2013 [cited November 20, 2013]. http://www.oed.com.
2. Colman MDE. Obesity in the paleolithic era? The Venus of Willendorf. Endocr Pract. 1998;4(1):58–9.
3. Tipton CM. Susruta of India, an unrecognized contributor to the history of exercise physiology. J Appl Physiol. 2008;104(6):1553–6. doi:10.1152/japplphysiol.00925.2007.
4. Gysel C. [Adolphe Quetelet (1796–1874). The statistics and biometry of growth]. Orthod Fr. 1974;45(1):643–77.
5. Obesity: Preventing and managing the global epidemic: World Health Organization; 2000.
6. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr. 2002;11:S732–7. doi:10.1046/j.1440-6047.11.s8.19.x.
7. Kang WY, Hwang SH, Hwang SH, et al. Effects of weight change on clinical outcomes in overweight and obese patients with acute myocardial infarction who underwent successful percutaneous coronary intervention. Chonnam Med J. 2012;48(1):32–8.
8. Bei-Fan Z, the Cooperative Meta-analysis Group of Working Group on Obesity in C. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr. 2002;11:S685–S93. doi:10.1046/j.1440-6047.11.s8.9.x.
9. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9. doi:10.1056/NEJMoa1000367.
10. Kalantar-Zadeh K, Streja E, Kovesdy CP, et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc. 2010;85(11):991–1001. doi:10.4065/mcp.2010.0336.
11. Curtis JP, Selter JG, Wang Y. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61. doi:10.1001/archinte.165.1.55.
12. Landbo C, Prescott E, Lange P, Vestbo J, Almdal T. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–61.
13. Oreopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V, Kalantar-Zadeh K. Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity. 2008;16(2):442–50. doi:10.1038/oby.2007.36.
14. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368(9536):666–78. doi:10.1016/S0140-6736(06)69251-9.
15. Altschule MD, Rosenfeld FM. Increased catabolism following acute myocardial infarction. Arch Intern Med. 1947;80(1):74–80. doi:10.1001/archinte.1947.00220130082007.
16. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.
17. Hoit BD, Gilpin EA, Maisel AA, Henning H, Carlisle J, Ross J Jr. Influence of obesity on morbidity and mortality after acute myocardial infarction. Am Heart J. 1987;114(6):1334–41. doi:10.1016/0002-8703(87)90534-5.
18. Lopez-Jimenez F, Jacobsen SJ, Reeder GS, Weston SA, Meverden RA, Roger VL. PRevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community*. Chest. 2004;125(4):1205–12. doi:10.1378/chest.125.4.1205.
19. Rana JS, Mukamal KJ, Morgan JP, Muller JE, Mittleman MA. Obesity and the risk of death after acute myocardial infarction. Am Heart J. 2004;147(5):841–6.
20. Eisenstein EL, McGuire DK, Bhapkar MV, et al. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Am J Med. 2005;118(9):981–90.
21. Kragelund C, Hassager C, Hildebrandt P, Torp-Pedersen C, Kober L. Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol. 2005;98(1):123–31. doi:10.1016/j.ijcard.2004.03.042.
22. Diercks DB, Roe MT, Mulgund J, et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the can rapid risk stratification of unstable angina patients suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J. 2006;152(1):140–8.
23. Goldberg RJ, Cui J, Olendzki B, et al. Excess body weight, clinical profile, management practices, and hospital prognosis in men and women after acute myocardial infarction. Am Heart J. 2006;151(6):1297–304.
24. Iakobishvili Z, Danicek V, Porter A, Assali AR, Battler A, Hasdai D. Is increased body mass index associated with a cardioprotective effect after ST-segment-elevation myocardial infarction? Acute Card Care. 2006;8(2):95–8. doi:10.1080/17482940600768673.
25. Nikolsky E, Stone GW, Grines CL, et al. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J. 2006;151(1):168–75. doi:10.1016/j.ahj.2005.03.024.
26. Wells B, Gentry M, Ruiz-Arango A, Dias J, Landolfo CK. Relation between body mass index and clinical outcome in acute myocardial infarction. Am J Cardiol. 2006;98(4):474–7. doi:10.1016/j.amjcard.2006.02.053.
27. Buettner HJ, Mueller C, Gick M, et al. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J. 2007;28(14):1694–701. doi:10.1093/eurheartj/ehm220.
28. Mehta L, Devlin W, McCullough PA, et al. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007;99(7):906–10. doi:10.1016/j.amjcard.2006.11.038.
29. Lopez-Jimenez F, Wu CO, Tian X, et al. weight change after myocardial infarction—the enhancing recovery in coronary heart disease patients (ENRICHD) experience. Am Heart J. 2008;155(3):478–84. doi:10.1016/j.ahj.2007.10.026.
30. Mehta RH, Gitt AK, Jünger C, et al. Body mass index and effectiveness of reperfusion strategies: implications for the management of patients with ST-elevation myocardial infarction. J Interv Cardiol. 2008;21(1):8–14. doi:10.1111/j.1540-8183.2007.00311.x.
31. Wienbergen H, Gitt A, Juenger C, et al. Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clin Res Cardiol. 2008;97(2):83–8. doi:10.1007/s00392-007-0585-x.
32. Aronson D, Nassar M, Goldberg T, Kapeliovich M, Hammerman H, Azzam ZS. The impact of body mass index on clinical outcomes after acute myocardial infarction. Int J Cardiol. 2010;145(3):476–80. doi:10.1016/j.ijcard.2009.12.029.
33. Hadi HAR, Zubaid M, AlMahmeed W, et al. The prevalence and outcome of excess body weight among middle eastern patients presenting with acute coronary syndrome. Angiology. 2010;61(5):456–64. doi:10.1177/0003319709355801.
34. Mahaffey KW, Tonev ST, Spinler SA, et al. Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial. Int J Cardiol. 2010;139(2):123–33.
35. Shechter M, Hammerman H, Boyko V, Hod H, Behar S, Matetzky S. The obesity paradox in hospitalized acute coronary syndrome patients in Israel: a national survey. CVD Prev Control. 2010;5(3):81–7. doi:10.1016/j.cvdpc.2010.08.002.
36. Das SR, Alexander KP, Chen AY, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction: results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2011;58(25):2642–50. doi:10.1016/j.jacc.2011.09.030.
37. Timóteo AT, Ramos R, Toste A, Oliveira JA, Ferreira ML, Ferreira RC. Impact of body mass index in the results after primary angioplasty in patients with ST segment elevation acute myocardial infarction. Acute Card Care. 2011;13(3):123–8. doi:10.3109/17482941.2011.606469.
38. Bucholz EM, Rathore SS, Reid KJ, et al. Body mass index and mortality in acute myocardial infarction patients. Am J Med. 2012;125(8):796–803.
39. Camprubi M, Cabrera S, Sans J, et al. Body mass index and hospital mortality in patients with acute coronary syndrome receiving care in a university hospital. J Obes. 2012;2012:5. doi:10.1155/2012/287939.
40. Lazzeri C, Valente S, Chiostri M, et al. Impact of age on the prognostic value of body mass index in ST-Elevation myocardial infarction. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2012.
41. Herrmann J, Gersh BJ, Goldfinger JZ, et al. Body mass index and acute and long-term outcomes after acute myocardial infarction (from the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial). Am J Cardiol. 2014;114(1):9–16.
42. Witassek F, Schwenkglenks M, Erne P, Radovanovic D. Impact of Body Mass Index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: does an obesity paradox exist? Swiss Med Wkly. 2014;144:w13986. doi:10.4414/smw.2014.13986.
43. Madala MC, Franklin BA, Chen AY, et al. Obesity and age of first non-st-segment elevation myocardial infarction. J Am Coll Cardiol. 2008;52(12):979–85. doi:10.1016/j.jacc.2008.04.067.
44. Peto R, Whitlock G, Jha P. Effects of obesity and smoking on US life expectancy. N Engl J Med. 2010;362(9):855–7. doi:10.1056/NEJMc1000079.
45. Kadakia MB, Fox CS, Scirica BM, Murphy SA, Bonaca MP, Morrow DA. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart. 2011;97(21):1782–7. doi:10.1136/heartjnl-2011-300231.
46. Clerico A, Giannoni A, Vittorini S, Emdin M. The paradox of low BNP levels in obesity. Heart Fail Rev. 2012;17(1):81–96. doi:10.1007/s10741-011-9249-z.
47. Abdulla J, Køber L, Abildstrøm SZ, Christensen E, James WPT, Torp-Pedersen C. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J. 2008;29(5):594–601. doi:10.1093/eurheartj/ehn010.
48. Osadnik T, Wasilewski J, Lekston A, et al. Comparison of modification of diet in renal disease and chronic kidney disease epidemiology collaboration formulas in predicting long-term outcomes in patients undergoing stent implantation due to stable coronary artery disease. Clin Res Cardiol. 2014;103(7):569–76. doi:10.1007/s00392-014-0687-1.
49. Angerås O, Albertsson P, Karason K, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2013;34(5):345–53. doi:10.1093/eurheartj/ehs217.
50. Zeller M, Steg PG, Ravisy J, et al. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation. 2008;118(5):482–90. doi:10.1161/circulationaha.107.753483.
51. Members: ATF, Perk J, De Backer G, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2012;33(13):1635–701. doi:10.1093/eurheartj/ehs092.
52. Members ATF, Steg PG, James SK, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012;. doi:10.1093/eurheartj/ehs215.
53. Sierra-Johnson J, Romero-Corral A, Somers VK, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil. 2008;15(3):336–40. doi:10.1097/HJR.0b013e3282f48348.
54. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82. doi:10.1001/jama.2012.113905.